Host cell protein dynamics in recombinant CHO cells

During the production of recombinant protein products, such as monoclonal antibodies, manufacturers must demonstrate clearance of host cell impurities and contaminants to appropriate levels prior to use in the clinic. These include host cell DNA and RNA, product related contaminants such as aggregates, and importantly host cell proteins (HCPs). Despite the importance of HCP removal, the identity and dynamics of these proteins during cell culture and downstream processing (DSP) are largely unknown. Improvements in technologies such as SELDI-TOF mass spectrometry alongside the gold standard technique of ELISA has allowed semi-quantification of the total HCPs present. However, only recently have techniques been utilized in order to identify those HCPs present and align this with the development of approaches to monitor the dynamics of HCPs during both fermentation and downstream processing. In order to enable knowledge based decisions with regards to improving HCP clearance it is vital to identify potential problematic HCPs on a cell line and product specific basis. Understanding the HCP dynamics will in the future help provide a platform to rationally manipulate and engineer and/or select suitable recombinant CHO cell lines and downstream processing steps to limit problematic HCPs.

[1]  Scott M Husson,et al.  Anion exchange membrane adsorbers for flow‐through polishing steps: Part II. Virus, host cell protein, DNA clearance, and antibody recovery , 2013, Biotechnology and bioengineering.

[2]  Daniel G Bracewell,et al.  The dynamics of the CHO host cell protein profile during clarification and protein A capture in a platform antibody purification process , 2013, Biotechnology and bioengineering.

[3]  Harald Kolmar,et al.  Host cell protein quantification by fourier transform mid infrared spectroscopy (FT‐MIR) , 2013, Biotechnology and bioengineering.

[4]  Guillaume Rey,et al.  Full automation and validation of a flexible ELISA platform for host cell protein and protein A impurity detection in biopharmaceuticals. , 2012, Journal of pharmaceutical and biomedical analysis.

[5]  G. C. Flynn,et al.  Identification and quantification of host cell protein impurities in biotherapeutics using mass spectrometry. , 2012, Analytical biochemistry.

[6]  Jianwei Zhu,et al.  Mammalian cell protein expression for biopharmaceutical production. , 2012, Biotechnology advances.

[7]  M. Aires-Barros,et al.  Fishing human monoclonal antibodies from a CHO cell supernatant with boronic acid magnetic particles. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[8]  Daniel G Bracewell,et al.  Host cell protein adsorption characteristics during protein a chromatography , 2012, Biotechnology progress.

[9]  P A Marichal-Gallardo,et al.  State‐of‐the‐art in downstream processing of monoclonal antibodies: Process trends in design and validation , 2012, Biotechnology progress.

[10]  Kelvin H. Lee,et al.  Chinese hamster genome database: an online resource for the CHO community at www.CHOgenome.org. , 2012, Biotechnology and bioengineering.

[11]  C. Smales,et al.  Host cell protein dynamics in the supernatant of a mAb producing CHO cell line , 2012, Biotechnology and bioengineering.

[12]  B. Nogal,et al.  Select host cell proteins coelute with monoclonal antibodies in protein a chromatography , 2012, Biotechnology progress.

[13]  G. Guiochon,et al.  Separation science is the key to successful biopharmaceuticals. , 2011, Journal of chromatography. A.

[14]  René Gantier,et al.  Antibody capture by mixed-mode chromatography: a comprehensive study from determination of optimal purification conditions to identification of contaminating host cell proteins. , 2011, Journal of chromatography. A.

[15]  M. Hurme,et al.  Economic comparison of diagnostic antibody production in perfusion stirred tank and in hollow fiber bioreactor processes , 2011, Biotechnology progress.

[16]  J. Taylor‐Papadimitriou,et al.  Transforming growth factor-β1 is constitutively secreted by Chinese hamster ovary cells and is functional in human cells. , 2011, Biotechnology and bioengineering.

[17]  J. Chon,et al.  Advances in the production and downstream processing of antibodies. , 2011, New biotechnology.

[18]  Shujun Bai,et al.  Fragmentation of a highly purified monoclonal antibody attributed to residual CHO cell protease activity. , 2011, Biotechnology and bioengineering.

[19]  Jennifer Zhang,et al.  Profiling of host cell proteins by two‐dimensional difference gel electrophoresis (2D‐DIGE): Implications for downstream process development , 2010, Biotechnology and bioengineering.

[20]  Hervé Broly,et al.  Degradation of an Fc‐fusion recombinant protein by host cell proteases: Identification of a CHO cathepsin D protease , 2009, Biotechnology and bioengineering.

[21]  M. Hoare,et al.  Ultra scale‐down prediction using microwell technology of the industrial scale clarification characteristics by centrifugation of mammalian cell broths , 2009, Biotechnology and bioengineering.

[22]  Niki S. C. Wong,et al.  2-D DIGE to expedite downstream process development for human monoclonal antibody purification. , 2009, Protein expression and purification.

[23]  A. Hunter,et al.  Host cell proteins in biologics development: Identification, quantitation and risk assessment , 2009, Biotechnology and bioengineering.

[24]  P. Hinckley,et al.  Host cell protein clearance during protein a chromatography: Development of an improved column wash step , 2008, Biotechnology progress.

[25]  Duncan Low,et al.  Future of antibody purification. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[26]  Reed J. Harris,et al.  Non-enzymatic hinge region fragmentation of antibodies in solution. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[27]  J. Nishihara,et al.  Proteomic Profiling of Recombinant Escherichia coli in High-Cell-Density Fermentations for Improved Production of an Antibody Fragment Biopharmaceutical , 2005, Applied and Environmental Microbiology.

[28]  P. Meleady,et al.  Proteomic Profiling of Secreted Proteins from CHO Cells Using Surface‐Enhanced Laser Desorption Ionization Time‐of‐Flight Mass Spectrometry , 2008, Biotechnology progress.

[29]  Heather Simmerman,et al.  Defining Your Product Profile and Maintaining Control Over It , Part 1 Session One of the WCBP CMC Strategy Forum , 19 – 20 July 2004 , 2005 .